Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
2028 Democratic Presidential Nomination Harvard-Harris Harris 39, Newsom 30, Buttigieg, Ocasio-Cortez 12, Shapiro 9, Kelly, Pritzker 7, Booker, Beshear, Moore Harris +9 2028 Republican Presidential ...